Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Mayne accused of deception

Posted 4 August 2021 PM

Generic drug maker Mayne Pharma has vowed to "vigorously defend" a class action filed in the Victorian Supreme Court in which it has been accused of "misleading and deceptive" conduct in relation to allegations of price-fixing by US authorities.

In an announcement to the Australian Stock Exchange, Mayne hit back at the allegations and promised to step up to the fight.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs